Followers | 0 |
Posts | 456 |
Boards Moderated | 0 |
Alias Born | 09/26/2009 |
Thursday, September 25, 2014 7:27:35 AM
1) This is not the same company as it was under Chris Stern
2) If you bought before September of last year you've gotten burned and lost over 90% of your money.
3) The company BEFORE September 2013 was ruined and only concerned with enriching the officers. Somewhere along the way John Kelley got involved and OXBT jumped at the chance of a new opportunity. Phyxius Pharma made the deal with OXBT so they didn't have to spend the time and $$$ to go public. And as you've seen, they've gained access to $56 million in capital to start clinical trials for LEVO in under a year and commenced those trials. Impressive in my book.
4) Now that John Kelley has come onboard he is making a real go at getting a different drug to market. These clinical trials are real and this drug meets an unmet need. Could it fail? Sure, most biotechs do. As far as the company not making a profit for 20 years, look at other bios, like ISIS or LIGND or centocore back in the day. They took 10 to 20 years to get their first drug approved.
5) Levo has a lower risk profile than most drugs becaues it has been in use in Europe for many years and there is ALOT of data on it already showing that it works and is safe.
6) $56 million that was raised was from an offering in May(dilution). That money is now in cash and purchased securities to fund the company. The company has stated "they have funds to sustain them until Mid 2017" so I would be shocked if there is anymore dilution before then.
7)7 hospitals are now participating in the trial, and over 30 will be online by the end of December. In just about 1 1/2 years the question of if this will be a successful company will be answered once and for all.
8) Oxycyte may still have a future as a drug, but I believe the real reason the trial was halted was not released to shareholders. I'm starting to think with all the crap that has happened in the past 10 years, all the record keeping of the clinical trials is a mess or lost and has to be re-done to present to the FDA for eventual approval so Kelley either has put it on hold and may sell to drug to another company or possibly restart if they are successful in getting LEVO approved.
Recent TENX News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2024 04:15:07 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/12/2024 08:15:28 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/10/2024 09:19:47 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/30/2024 08:20:02 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/19/2024 10:48:03 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/19/2024 08:15:15 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/15/2024 08:19:12 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/14/2024 10:47:35 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/14/2024 07:19:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:45:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:35:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 11:43:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 11:42:23 PM
- Biotech Soars Following Oversubscribed $100M Private Placement Announcement • AllPennyStocks.com • 08/06/2024 08:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:23:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:32:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:01:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:00:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:01:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:01:43 PM
- Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM